DAEJEON, REPUBLIC OF KOREA, September 20, 2017 /24-7PressRelease/
-- Kang Min-Woong, MD, PhD, has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
A young leader in the Korean medical field, Dr. Kang has risen from a newly christened doctor to chief of the thoracic division in the department of thoracic and cardiovascular surgery at Chungnam National University Hospital in only 14 years. He is well renowned in both regional and international medical societies, and is known for his development of the surgical linear stapler. As of 2015, Dr. Kang concurrently serves as chief executive officer of Meditulip, a medical device venture company that manufactures his minimally invasive surgical devices, which have been applied in cancer operations.
Born in Republic of Korea, Dr. Kang matriculated with Chungnam National University to become a doctor, and in accordance with the Republic of Korean medical industry, served the equivalent of his internship and residency at the esteemed institution. He joined the renowned Samsung Medical Center in 2008, and served a one year fellowship while earning a PhD from Chungnam National University. Dr. Kang was immediately accepted as a clinical professor of his alma mater, and went on to become an assistant professor in 2011. As of 2016, he serves as an associate professor of the university, and in 2017, Dr. Kang was promoted to chief of the thoracic division.
As a rising star in the cardiovascular surgery field, Dr. Kang made great strides in advancing the tools of the trade, and was honored with a 2010 Johnson and Johnson Medical Award as well as a 2009 Scientific Award from the Korean Society for Thoracic and Cardiovascular Surgery. According to Meditulip's website, Johnson and Johnson along with Medtronic occupy approximately 93 percent of the global market for surgical staplers, and Dr. Kang's company was established in 2015 to offer an alternative product for surgeons to choose from.
Dr. Kang currently holds four domestic patents on his device, and is in discussions for international patents in China, the U.S., Japan, Europe, and India. Meditulip is completely established by the university faculty of Chungnam National University, and it was selected as a Chungbuk Industry University Cooperation Research and Development Enterprise. Furthermore, Meditulip was chosen for the TIPS program.
Dr. Kang's developments have been well received by the Korean medical community, and he was chosen as a faculty member of the second Asian Single Port VATS Surgery Symposium in 2014. He is a member of the scientific committees of the Korean Society for Thoracic and Cardiovascular Surgery and the Korean Society for Thoracic Oncologic Surgery. Additionally, Dr. Kang has notably supported the Korean Association for Lung Cancer Society, the Korean Association for the Study of Lung Cancer, the International Association for the Study of Lung Cancer, and the editorial board of the Korean Association for the Study of Lung Cancer. For more information about Dr. Kang's innovations, please visit http://www.meditulip.com
About Marquis Who's Who :
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America , Marquis Who's Who has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis publications may be visited at the official Marquis Who's Who website at www.marquiswhoswho.com